Clinical trial
Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant…
NCT00337493 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00337493 |
|---|---|
| Title | Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients. |
| Official title | A Study to Investigate the Impact of Pharmacogenetics on CellCept Use, in Patients Participating in a Study in Renal Transplantation |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | mycophenolate mofetil [CellCept], Cyclosporine or tacrolimus |
| Enrollment | 155 |
| Start date | Dec 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Jun 16, 2006 |
| Last update posted | Sep 17, 2012 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: